Loading...

Jeffrey Gertsch

TitleAssociate Clinical Professor
InstitutionUniversity of California San Diego
DepartmentNeurosciences
Address200 W. Arbor Drive #8465
San Diego CA 92103
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mandeville RM, Brown JM, Gertsch J, Allison DW. Use of Posterior Root-Muscle Reflexes in Peripheral Nerve Surgery: A Case Report. Neurodiagn J. 2016; 56(3):178-185. PMID: 28436768.
      View in: PubMed
    2. Allison DW, Allen RT, Kohanchi DD, Skousen CB, Lee YP, Gertsch J. Vasculopathy, Ischemia, and the Lateral Lumbar Interbody Fusion Surgery: Report of Three Cases. J Clin Neurophysiol. 2015 Dec; 32(6):e41-5. PMID: 26629762.
      View in: PubMed
    3. Sracic MK, Thomas D, Pate A, Norris J, Norman M, Gertsch J. Syndrome of acute anxiety among marines after recent arrival at high altitude. Mil Med. 2014 May; 179(5):559-64. PMID: 24806502.
      View in: PubMed
    4. Allison DW, Gertsch J, Mahan MA, Sheean GL, Brown JM. Anesthesia considerations for monitoring TCMEPs in adults diagnosed with poliomyelitis as children: a case report. Neurodiagn J. 2014 Mar; 54(1):28-35. PMID: 24783748.
      View in: PubMed
    5. Gertsch J, Holck PS, Basnyat B, Corbett BM. In reply to "ibuprofen for prevention of acute mountain sickness-is bigger really better?". Wilderness Environ Med. 2013 Jun; 24(2):178-9. PMID: 23725595.
      View in: PubMed
    6. Gertsch J, Corbett B, Holck PS, Mulcahy A, Watts M, Stillwagon NT, Casto AM, Abramson CH, Vaughan CP, Macguire C, Farzan NN, Vo BN, Norvelle RJ, May K, Holly JE, Irons H, Stutz AM, Chapagain P, Yadav S, Pun M, Farrar J, Basnyat B. Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. Wilderness Environ Med. 2012 Dec; 23(4):307-15. PMID: 23098412.
      View in: PubMed
    7. Lipman GS, Gertsch J. Pharmacologic prevention for acute mountain sickness-lack of appropriate inclusion of the available evidence. Ann Emerg Med. 2012 Oct; 60(4):538-9. PMID: 23010187.
      View in: PubMed
    8. Lipman GS, Kanaan NC, Holck PS, Constance BB, Gertsch J. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med. 2012 Jun; 59(6):484-90. PMID: 22440488.
      View in: PubMed
    9. Brandling-Bennett EM, Bookheimer SY, Horsfall JL, Moftakhar P, Sedrak M, Barkulis CT, Gertsch J, MacDougall MG, Boucharel W, Nuwer MR, Bergsneider M. A paradigm for awake intraoperative memory mapping during forniceal stimulation. Neurocase. 2012 Feb; 18(1):26-38. PMID: 21714760.
      View in: PubMed
    10. Basnyat B, Holck PS, Pun M, Halverson S, Szawarski P, Gertsch J, Steif M, Powell S, Khanal S, Joshi A, Shankar R, Karambay J, Alexander HD, Stone A, Morrissey C, Thompson BH, Farrar J. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Wilderness Environ Med. 2011 Mar; 22(1):15-22. PMID: 21377114.
      View in: PubMed
    11. Gertsch J, Lipman GS, Holck PS, Merritt A, Mulcahy A, Fisher RS, Basnyat B, Allison E, Hanzelka K, Hazan A, Meyers Z, Odegaard J, Pook B, Thompson M, Slomovic B, Wahlberg H, Wilshaw V, Weiss EA, Zafren K. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ Med. 2010 Sep; 21(3):236-43. PMID: 20832701.
      View in: PubMed
    12. Basnyat B, Gertsch J, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. High Alt Med Biol. 2006; 7(1):17-27. PMID: 16544963.
      View in: PubMed
    13. Gertsch J, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ. 2004 Apr 03; 328(7443):797. PMID: 15070635; PMCID: PMC383373.
    14. Basnyat B, Wu T, Gertsch J. Neurological conditions at altitude that fall outside the usual definition of altitude sickness. High Alt Med Biol. 2004; 5(2):171-9. PMID: 15265338.
      View in: PubMed
    15. Gertsch J, Wood C. Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosis. Hawaii Med J. 2003 Jun; 62(6):127, 129. PMID: 12886727.
      View in: PubMed
    16. Basnyat B, Gertsch J, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol. 2003; 4(1):45-52. PMID: 12713711.
      View in: PubMed
    17. Gertsch J, Seto TB, Mor J, Onopa J. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt Med Biol. 2002; 3(1):29-37. PMID: 12006162.
      View in: PubMed